Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company 4D Pharma plc
DescriptionLive biotherapeutic comprised of live microorganisms
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis in pediatric patients
Regulatory Designation U.S. - Orphan Drug (Treat ulcerative colitis in pediatric patients)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today